26 sessions available

Friday August 15

8:30 AM - 9:30 AM
breakfast

Breakfast

⏱️ In Progress0
9:30 AM - 9:55 AM
plenary

Official Opening-Welcome Address

⏱️ In Progress0
10:00 AM - 10:30 AM
keynote

Keynote: Global Advocacy including Registry Initiatives Supporting Management of Sickle Cell Disease

⏱️ In Progress0
10:35 AM - 11:35 AM
plenary

Plenary: Ontario Health: An Update on the Implementation of the Quality Standards for Sickle Cell Disease

⏱️ In Progress0
11:40 AM - 12:00 PM
break

Morning Break

⏱️ In Progress0
12:05 PM - 12:20 PM
plenary

Oral Abstract Presentations

  • Co-Designing High-Quality, Culturally Safe Sickle Cell Disease Care Through Community and Health System Collaboration
  • Reflections from Patients with SCD in Ontario on Hospital Care Experiences
⏱️ In Progress0
12:30 PM - 1:30 PM
lunch

Lunch / Poster Presentation

  • What can emergency department sickle cell champions tell us about providing high quality care?
  • The Global Action Network for Sickle Cell & Other Inherited Blood Disorders: A Cross-Disease Initiative to Address Challenges in Inherited Blood Disorders
  • Promoting a healthier future
  • Evidence2Practice and North York General Hospital: Bridging Gaps in Care for Sickle Cell Disease
  • Expansion of Lakeridge Health’s Equity Quality Improvement Project for Sickle Cell Disease: From Ajax to Oshawa and Beyond To Improve Access to Evidence Based, Equitable Care For People with Sickle Cell Disease
  • Understanding cognitive impairment in children with sickle cell anemia: linking cerebrovascular impairment to brain activations
⏱️ In Progress0
1:35 PM - 2:35 PM
patient-track

Sickle Cell: What every patient and parent needs to know about sickle cell disease

Concurrent session for patients

⏱️ In Progress0
1:35 PM - 2:35 PM
provider-track

Best Practices in Prescribing Disease Modifying Therapies in SCD

Concurrent session for providers.

⏱️ In Progress0
2:40 PM - 3:40 PM
patient-track

Equity and Inclusion in Blood Donation

Concurrent session for patients.

⏱️ In Progress0
2:40 PM - 3:40 PM
provider-track

Alloimmunization and Hyperhemolysis in SCD

Concurrent session for providers.

⏱️ In Progress0
3:40 PM - 3:55 PM
break

Break

⏱️ In Progress0
4:00 PM - 5:00 PM
plenary

Comprehensive Models of Sickle Cell Disease Care

⏱️ In Progress0

Saturday August 16th

8:30 AM - 9:30 AM
breakfast

Breakfast

⏱️ In Progress0
9:35 AM - 9:45 AM
plenary

Welcome Remarks

⏱️ In Progress0
9:45 AM - 10:15 AM
keynote

Keynote: Creating a Connected Community to Improve Sickle Cell Care - Community of Practice and other Strategies to Advance Sickle Cell Care

⏱️ In Progress0
10:20 AM - 11:20 AM
plenary

Health Care Providers and Community as Partners in Advancing SCD Care and Treatment

⏱️ In Progress0
11:25 AM - 11:40 AM
break

Break

⏱️ In Progress0
11:40 AM - 12:40 PM
patient-track

Future Innovation in Patient Pain Management for Sickle Cell Disease

Concurrent session for patients.

⏱️ In Progress0
11:40 AM - 12:40 PM
provider-track

What's Hot in Cell and Gene Therapy: Which Should I Recommend and When?

Concurrent session for providers.

⏱️ In Progress0
12:45 PM - 1:00 PM
plenary

Oral Abstract Presentation

Presentation of selected research abstracts.

⏱️ In Progress0
1:00 PM - 2:00 PM
lunch

Lunch / Poster Presentations

Reflections from Patients with SCD on Hospital Care Experiences in Ontario

  • Co-Designing High-Quality, Culturally Safe Sickle Cell Disease Care Through Community and Health System CollaborationCo-Designing High-Quality, Culturally Safe Sickle Cell Disease Care Through Community and Health System Collaboration
  • Reflections from Patients with SCD in Ontario on Hospital Care Experiences
  • What can emergency department sickle cell champions tell us about providing high quality care?
  • Promoting a healthier future
  • Evidence2Practice and North York General Hospital: Bridging Gaps in Care for Sickle Cell Disease
  • Expansion of Lakeridge Health’s Equity Quality Improvement Project for Sickle Cell Disease: From Ajax to Oshawa and Beyond To Improve Access to Evidence Based, Equitable Care For People with Sickle Cell Disease
  • Understanding cognitive impairment in children with sickle cell anemia: linking cerebrovascular impairment to brain activations
⏱️ In Progress0
2:00 PM - 3:00 PM
patient-track

Curative Therapies in Sickle Cell Disease

Concurrent session for patients.

⏱️ In Progress0
2:00 PM - 3:00 PM
provider-track

Acute Chest Syndrome and Pulmonary Hypertension – How to Spot It and The Best Way to Treat It

Concurrent session for providers.

⏱️ In Progress0
3:05 PM - 4:05 PM
plenary

Genetic Screening for Inherited Blood Disorders and Sickle Cell Trait in Canada

⏱️ In Progress0
4:10 PM - 4:15 PM
plenary

Closing Remarks

⏱️ In Progress0

Sponsored By

Sponsored By

Vertex logo
Vertex logo
Vertex logo
novo nordisk logo
Public Health Agency of Canada logo
Public Health Agency of Canada logo
Public Health Agency of Canada logo
Chiesi logo
Chiesi logo
Chiesi logo
Canadian Blood Services Logo
Canadian Blood Services Logo
Canadian Blood Services Logo

August 15-16th, 2025

Sheraton Toronto Airport Hotel & Conference Centre

Sponsored By

Vertex logo
Vertex logo
novo nordisk logo
Public Health Agency of Canada logo
Public Health Agency of Canada logo
Chiesi logo
Chiesi logo
Canadian Blood Services Logo
Canadian Blood Services Logo

Quick Links

Contact

Address: 330-5109 Steeles Ave W.
North York, ON , M9L 2Y8


Phone: GTA: 416-745-4267


Email: info@sicklecellanemia.ca

Got a Question?

Want to Support Us?

© SCAGO - All Rights Reserved -Disclaimer - Charitable Registration #: 83332 0872 RR 0001

Quick Links

Contact

Address: 330-5109 Steeles Ave W.

North York, ON M9L 2Y8


Phone: 416-745-4267


Email: info@sicklecellanemia.ca

Got a Question?

Want to Support Us?

© SCAGO - All Rights Reserved -Disclaimer - Charitable Registration #: 83332 0872 RR 0001

Contact

Address: 330-5109 Steeles Ave W.
North York, ON M9L 2Y8


Phone: 416-745-4267


Email: info@sicklecellanemia.ca

Got a Question?

Want to Support Us?

© SCAGO - All Rights Reserved -Disclaimer - Charitable Registration #: 83332 0872 RR 0001